ENACCT Policy Webinar Series: December 2012
Ensuring Equal Access to Cancer Research: How does Bias Play a Role in who is Offered Clinical Trial Participation?
December 11, 2012; 1:00-2:30pm ET
Studies have found that very few cancer patients are informed about the option of participating in a cancer clinical trial. Even at major cancer centers, oncologists may not approach all eligible patients about participation and patients from minority groups or who are 65 or older may be less likely to be approached, regardless of eligibility. It has been suggested that providers’ implicit bias, rather than overt prejudice, can influence provider clinical decision making and quality of care delivered, contributing to treatment disparities. This webinar will review the literature on these biases and explore strategies for managing bias to maximize opportunities for equal patient access to cancer clinical trials.
- Consider the role of provider behavior on medical decision making in the clinical trial setting
- Explore approaches to maximize identification and enrollment of all trial eligible patients
- Identify effective approaches to communicate trial concepts with patients
Terrance L. Albrecht, Ph.D.
Associate Center Director, Population Sciences Leader, Population Studies and Disparities Research Program Karmanos Cancer Institute Professor and Associate Director, Dept. of Oncology, WSU School of Medicine
Carma Bylund, Ph.D.
Director, Communication Skills Training and Research Laboratory Associate Attending Behavioral Scientist Dept. of Psychiatry and Behavioral Sciences Memorial Sloan-Kettering Cancer Center
|Ensuring Equal Access to Cancer Research: How does Bias Play a Role in who is Offered Clinical Trial Participation?.pdf||310.29 KB|